GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » Gross Profit

Iran Daru (XTEH:IRDR1) Gross Profit : IRR0.00 Mil (TTM As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Iran Daru Gross Profit?

Iran Daru's gross profit for the six months ended in . 20 was IRR0.00 Mil. Iran Daru's gross profit for the trailing twelve months (TTM) ended in . 20 was IRR0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Iran Daru's gross profit for the six months ended in . 20 was IRR0.00 Mil. Iran Daru's Revenue for the six months ended in . 20 was IRR0.00 Mil. Therefore, Iran Daru's Gross Margin % for the quarter that ended in . 20 was N/A%.

Iran Daru had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage


Iran Daru Gross Profit Historical Data

The historical data trend for Iran Daru's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iran Daru Gross Profit Chart

Iran Daru Annual Data
Trend
Gross Profit

Iran Daru Semi-Annual Data
Gross Profit

Competitive Comparison of Iran Daru's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Iran Daru's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Iran Daru's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Iran Daru's Gross Profit distribution charts can be found below:

* The bar in red indicates where Iran Daru's Gross Profit falls into.



Iran Daru Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Iran Daru's Gross Profit for the fiscal year that ended in . 20 is calculated as

Gross Profit (A: . 20 )=Revenue - Cost of Goods Sold
= -
=0.00

Iran Daru's Gross Profit for the quarter that ended in . 20 is calculated as

Gross Profit (Q: . 20 )=Revenue - Cost of Goods Sold
= -
=0.00

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Gross Profit for the trailing twelve months (TTM) ended in . 20 was IRR0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Iran Daru's Gross Margin % for the quarter that ended in . 20 is calculated as

Gross Margin % (Q: . 20 )=Gross Profit (Q: . 20 ) / Revenue (Q: . 20 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 /
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Iran Daru  (XTEH:IRDR1) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Iran Daru had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage


Iran Daru Gross Profit Related Terms

Thank you for viewing the detailed overview of Iran Daru's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Iran Daru (XTEH:IRDR1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ayatollah Saeedi Highway, End Of Kermani Street, Moallem Boulevard, Tehran, IRN, 1371658111
Iran Daru is a pharmaceutical company based in Iran. It manufactures and sells pharmaceutical products for antibiotics, cardiovascular agents, and local anesthetic agents. The company manufactures products in three main dosage form categories namely solid, semi-solid, and liquid including tablets, capsules, pellets, sachets, gels, creams, ointments (sterile and non-sterile), spray solutions, and syrups. Products offered by Iran Daru include Diclofenac Potassium, Biotin 5 mg, Tetracycline, Folic acid, Meloxicam, Acetaminophen and Caffeine, and Levocetirizine dihydrochloride, among others. It also exports its products to other countries.

Iran Daru (XTEH:IRDR1) Headlines

No Headlines